N	Concordance
1	l-trans-retinoic acid (RA) is used as a differentiation therapy for acute 
2	s type of leukemia. trans-Retinoic acid differentiation therapy can induce compl
3	       Due to advances in chemotherapy, differentiation therapy and bone marrow 
4	myosin. We suggest a potential role for differentiation therapy as a therapeutic
5	      resistance is a major obstacle in differentiation therapy for RMS. 27 UI 
6	ination with vitamin D analogues in the differentiation therapy for myeloid leuk
7	toconazole) may offer a new approach to differentiation therapy and address the 
8	 Therapy plus Single-Agent Chemotherapy/Differentiation Therapy. Interferon alf